Vertiflex previously offloaded its noncore spinal implant assets to Stryker back in 2013 for an undisclosed price to raise money to fund the clinical development of its Superion system. (Boston ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Orthopaedic and Rehabilitation Devices Panel of the ...

VertiFlex gained a PMA approval for its Superion Interspinous Spacer System to treat spinal stenosis. The device is designed to be the least invasive, motion-preserving spinal spacer device. The ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced the completion of enrollment in ...

Technology: VertiFlex develops minimally invasive products for the treatment of lumbar spinal stenosis. Its Superion Interspinous Spacer system was approved by the FDA last year and is "designed to ...

Spacer to countries outside the USA. The Superion implant is placed percutaneously between the spinous processes without the need to cut paraspinal muscles. It is primarily designed to offer relief ...

VertiFlex earned FDA PMA Approval Order for the Superion Interspinous Spacer System. 1. Earlier this year, the FDA Advisory Panel voted that Superion demonstrated safety and effectiveness and a ...

(MENAFN- GetNews) DelveInsight's latest report on“Interspinous Spacers Market Insights, Competitive Landscape, and Market Forecast 2026” report covers an in-depth understanding of the historical & ...